Compound Summary
Nolinospiroside F
Compound Information
Nolinospiroside F
Compound Name: | Nolinospiroside F |
Compound CID: | 86289919 |
Synonyms: | Nolinospiroside F CHEBI:82654 Q27156174 (1beta,3beta,25S)-3-(6-deoxy-alpha-L-mannopyranosyl)oxyspirost-5-en-1-yl 6-deoxy-beta-D-galactopyranoside More... |
Iupac Name: | (2R,3R,4S,5R,6R)-2-methyl-6-[(1S,2S,4S,5'S,6R,7S,8R,9S,12S,13R,14R,16R)-5',7,9,13-tetramethyl-14-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxyoxane-3,4,5-triol |
InChI: | InChI=1S/C39H62O12/c1-17-9-12-39(46-16-17)18(2)28-26(51-39)15-25-23-8-7-21-13-22(49-35-33(44)31(42)29(40)19(3)47-35)14-27(38(21,6)24(23)10-11-37(25,28)5)50-36-34(45)32(43)30(41)20(4)48-36/h7,17-20,22-36,40-45H,8-16H2,1-6H3/t17-,18-,19+,20-,22+,23+,24-,25-,26-,27+,28-,29-,30-,31-,32+,33+,34+,35-,36-,37-,38-,39+/m0/s1 |
InChIKey: | RMIQIULKBBCLIL-IXASQKICSA-N |
Canonical Smiles: | CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(C(CC(C6)OC7C(C(C(C(O7)C)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)C)OC1 |
Isomeric Smiles: | C[C@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5([C@@H](C[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)C)O)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)C)OC1 |
Molecular Weight: | 722.9 |
Molecular Formula: | C39H62O12 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Nolinospiroside F
Molecular Weight: | 722.9 |
Molecular Formula: | C39H62O12 |
Hydrogen Bond Donor Count: | 6 |
Hydrogen Bond Acceptor Count: | 12 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 51 |
Complexity: | 1330 |
Synonyms
Nolinospiroside F
| Nolinospiroside F | Nolinospiroside F |
|---|---|
Nolinospiroside F |
CHEBI:82654 |
Q27156174 |
(1beta,3beta,25S)-3-(6-deoxy-alpha-L-mannopyranosyl)oxyspirost-5-en-1-yl 6-deoxy-beta-D-galactopyranoside |
Experimental Data
Nolinospiroside F
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saccharomyces cerevisiae | 10.000000000000000 | umol/L | 6.430000000000000 | 7.800000000000000 | 0.210000000000000 | S | K6001 | 23439553 | Active | ||||
| Saccharomyces cerevisiae | 3.000000000000000 | umol/L | 6.430000000000000 | 7.880000000000000 | 0.230000000000000 | S | K6001 | 23439553 | Active | ||||
| Saccharomyces cerevisiae | 1.000000000000000 | umol/L | 6.430000000000000 | 7.650000000000000 | 0.190000000000000 | S | K6001 | 23439553 | Active |
Experimental Data Visualization
Nolinospiroside F
Statistics Data
Nolinospiroside F
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Saccharomyces cerevisiae | 0.230000000000000 | 1 | 3 |
Statistics Data Visualization
Nolinospiroside F
